Masimo O3 Regional Oximetry Device in Pediatric Patients Undergoing Cardiac Surgery

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 16, 2020

Primary Completion Date

September 30, 2021

Study Completion Date

October 5, 2021

Conditions
Pediatric Cardiac Surgery
Interventions
DEVICE

Masimo O3

"After anesthesia induction, a masimo O3 sensors are attached to the forehead (ScO2) and the sole of the foot (StO2). About 0.4 ml blood samples are obtained from arterial line and central venous line at three epochs before and after cardiopulmonary bypass (total 6 times)~* T1: before cardiopulmonary bypass (CPB), fraction of inspired oxygen (FiO2) 0.2~* T2: before CPB, FiO2 0.5~* T3: before CPB, FiO2 0.8~* T4: after CPB, FiO2 0.8~* T5: after CPB, FiO2 0.5~* T6: after CPB, FiO2 0.2~Hemoglobin oxygen saturation values are confirmed in each sample (arterial sample: SaO2, venous sample: SvO2). Each O3 values (ScO2 and StO2) are compared to the values of SvO2, 0.7 × SvO2 + 0.3 × SaO2."

Trial Locations (1)

03080

Seoul National University Hospital, Seoul

All Listed Sponsors
lead

Seoul National University Hospital

OTHER

NCT04208906 - Masimo O3 Regional Oximetry Device in Pediatric Patients Undergoing Cardiac Surgery | Biotech Hunter | Biotech Hunter